Patents by Inventor Behjatolah M. Karbassi

Behjatolah M. Karbassi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of cancer metastasis
    Patent number: 9556256
    Abstract: P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: January 31, 2017
    Assignee: The Board of Trustees of The University of Arkansas
    Inventors: Behjatolah M. Karbassi, Thomas Kieber-Emmons
  • INHIBITION OF CANCER METASTASIS
    Publication number: 20140248290
    Abstract: P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis.
    Type: Application
    Filed: April 5, 2012
    Publication date: September 4, 2014
    Applicant: The Board of Trustees of the University of Arkansas
    Inventors: Behjatolah M. Karbassi, Thomas Kieber-Emmons
  • Inhibition of cancer metastasis
    Patent number: 8173103
    Abstract: P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis.
    Type: Grant
    Filed: October 4, 2008
    Date of Patent: May 8, 2012
    Assignee: The Board of Trustees of the University of Arkansa
    Inventors: Behjatolah M. Karbassi, Thomas Kieber-Emmons
  • Inhibition of cancer metastasis
    Publication number: 20090136488
    Abstract: P-Selectin on platelets and endothelium binds cell surface chondroitin sulfate (CS) proteoglycans, which are abundantly and stably expressed on the surface many cancer cells. Binding of the cancer cells through the CS moieties may be blocked to inhibit the interaction of cancer cells with platelets and endothelium. The present inventors disclose compositions and methods for the inhibition of cancer metastasis.
    Type: Application
    Filed: October 4, 2008
    Publication date: May 28, 2009
    Applicant: The Board of Trustees of the University of Arkansa
    Inventors: Behjatolah M. Karbassi, Thomas Kieber-Emmons